Virginie Baylot

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

16h-index3.0kcitations32works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(9), Heat shock proteins research(7), Immune Cell Function and Interaction(4), Cancer, Stress, Anesthesia, and Immune Response(4), Cancer Immunotherapy and Biomarkers(3)

Publications31 total

Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E
Oncogene·2025Open Access
Author Correction: Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs
Communications Biology·2025Open Access
Editorial Expression of Concern: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E
Oncogene·2025Open Access
Control of cancer cell phenotypes <i>via</i> supramolecular hydrogels: the role of extracellular matrix stiffness
Materials Advances·2025· 1 citedOpen Access
NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myeloma
Blood·2024· 16 citedOpen Access
Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs
Communications Biology·2024· 28 citedOpen Access
TCTP regulates genotoxic stress and tumorigenicity via intercellular vesicular signaling
EMBO Reports·2024· 2 citedOpen Access
Inflamed Natural Killer cells with adhesion defects are associated with a poor prognosis in Multiple Myeloma
2024Open Access
New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex
Pharmaceuticals·2023Open Access
Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments
Cancers·2023· 86 citedOpen Access
CCDC 2237246: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
Synthesis, Crystal Structure and Anti-Leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
Molbank·2023· 1 citedOpen Access
MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity
eLife·2020· 69 citedOpen Access
Author response: MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity
2019Open Access
Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer·2018· 142 citedOpen Access
The MYC oncogene is a global regulator of the immune response
Blood·2018· 260 cited
Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
Oncotarget·2017· 44 citedOpen Access
RETRACTED: Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer
Journal of Controlled Release·2017· 61 citedOpen Access
MYC: Master Regulator of Immune Privilege
Trends in Immunology·2017· 105 citedOpen Access
TCTP Has a Crucial Role in the Different Stages of Prostate Cancer Malignant Progression
Results and problems in cell differentiation·2017· 10 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Palma Rocchi(16), David Taïeb(8), Dean W. Felsher(7), Carmen Garrido(6), Camille Andrieu(5), Alan So(5), Juan Iovanna(5), Julie Acunzo(5), Ian Lai(4), Renumathy Dhanasekaran(4), Ladan Fazli(4), Martin Gleave(4), Maria Katsogiannou(4), Claudia Andrieu(4), Stephanie C. Casey(3), Ling Tong(3), Meital Gabay(3), Aurélie de Thonel(3), Franck Bladou(3), Sophie Giusiano(3)